Wed, May 20, 2020
Tue, May 19, 2020
Mon, May 18, 2020

Charles Duncan Reiterated (CARA) at Buy with Increased Target to $40 on, May 19th, 2020

Charles Duncan of Cantor Fitzgerald, Reiterated "Cara Therapeutics, Inc." (CARA) at Buy with Increased Target from $34 to $40 on, May 19th, 2020.

Charles, nor any peers, have made any analyst calls on CARA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30